Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-11-28 HILZINGER KURT J Director Other acquisition +11,633 11,633
2016-11-28 HILZINGER KURT J Director Other acquisition · Warrant (Right to Buy) +12,036 12,036
2016-11-28 Canute Scott A Director Other acquisition +57,408 246,342
2016-11-28 Canute Scott A Director Other acquisition · Warrant (Right to Buy) +37,315 37,315
2016-11-23 Griffith Donald J. Director Sale −1 $3.75 $4 144,926
2016-11-11 Gangloff Scott A. SVP, Development & Mfrg Sale −37,369 $3.75 $140K 78,573
2016-11-11 MCANDREW STEPHEN J SVP Bus. Strat. & Dev. Sale −21,367 $3.75 $80K 36,604
2016-11-09 Gangloff Scott A. SVP, Development & Mfrg Conversion −115,942 0
2016-11-09 Gangloff Scott A. SVP, Development & Mfrg Exercise or conversion +115,942 115,942
2016-11-09 Griffith Donald J. Director Conversion −144,927 0
2016-11-09 Griffith Donald J. Director Exercise or conversion +144,927 144,927
2016-11-09 MCANDREW STEPHEN J SVP Bus. Strat. & Dev. Conversion −57,971 0
2016-11-09 MCANDREW STEPHEN J SVP Bus. Strat. & Dev. Exercise or conversion +57,971 57,971
2016-11-09 Canute Scott A Director Conversion −57,971 0
2016-11-09 Canute Scott A Director Exercise or conversion +57,971 188,934
2016-11-09 Brady Todd C Director Conversion −28,985 28,985
2016-11-09 Brady Todd C Director Exercise or conversion +28,985 153,288
2016-05-18 Mohan Pankaj President & CEO Conversion · Series A Preferred Stock −106 0
2016-05-18 Canute Scott A Director Conversion +58,500 130,963
2016-05-18 Canute Scott A Director Conversion · Series A Preferred Stock −351 0

Page 19 of 20 · 386 trades